Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer
Author:
Publisher
Frontiers Media SA
Subject
General Medicine
Reference198 articles.
1. 4-year survival and outcomes after cessation of pembrolizumab (pembro) after 2-years in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in KEYNOTE-006;Long;J Clin Oncol,2018
2. Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma who received dabrafenib combined with trametinib;Long;J Clin Oncol,2018
3. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med.,2010
4. Safety, activity, and immune correlates of anti–PD-1 antibody in cancer;Topalian;N Engl J Med.,2012
5. Safety and activity of anti–PD-L1 Antibody in patients with advanced cancer;Brahmer;N Engl J Med,2012
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response;BJC Reports;2024-06-24
2. Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer;iScience;2024-02
3. Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy;Journal of Clinical Pathology;2024-01-19
4. Protective Mechanisms of Polyphenol-Enriched Blueberry Preparation in Preventing Inflammation in the Skin against UVB-Induced Damage in an Animal Model;Antioxidants;2023-12-21
5. Positional proteomics: is the technology ready to study clinical cohorts?;Expert Review of Proteomics;2023-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3